Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Tschulik

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|December 16, 2006
Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemiaMartin Weisser, Wolfgang Kern, Claudia Schoch, et al.
British Journal of Haematology|July 24, 2009
RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemiaSusanne Schnittger, Ulrike Bacher, Wolfgang Kern, et al.
Blood|July 10, 2009
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AMLSusanne Schnittger, Wolfgang Kern, Claudia Tschulik, et al.
Blood|August 4, 2005
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotypeSusanne Schnittger, Claudia Schoch, Wolfgang Kern, et al.
Communications Biology|June 5, 2023
Activation-inducible CAR expression enables precise control over engineered CAR T cell functionSimon P Fraessle, Claudia Tschulik, Manuel Effenberger, et al.
Journal of Immunological Methods|January 12, 2024
Miniaturized CAR knocked onto CD3ε extends TCR function with CAR specificity under control of endogenous TCR signaling cascadeKatrin Manske, Lisa Dreßler, Simon P Fräßle, et al.
Plos One|May 1, 2012
Novel serial positive enrichment technology enables clinical multiparameter cell sortingChristian Stemberger, Stefan Dreher, Claudia Tschulik, et al.
Scientific Reports|October 21, 2020
Expamers: a new technology to control T cell activationMateusz P Poltorak, Patricia Graef, Claudia Tschulik, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|December 16, 2006
Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemiaMartin Weisser, Wolfgang Kern, Claudia Schoch, et al.
British Journal of Haematology|July 24, 2009
RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemiaSusanne Schnittger, Ulrike Bacher, Wolfgang Kern, et al.
Blood|July 10, 2009
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AMLSusanne Schnittger, Wolfgang Kern, Claudia Tschulik, et al.
Blood|August 4, 2005
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotypeSusanne Schnittger, Claudia Schoch, Wolfgang Kern, et al.
Communications Biology|June 5, 2023
Activation-inducible CAR expression enables precise control over engineered CAR T cell functionSimon P Fraessle, Claudia Tschulik, Manuel Effenberger, et al.
Journal of Immunological Methods|January 12, 2024
Miniaturized CAR knocked onto CD3ε extends TCR function with CAR specificity under control of endogenous TCR signaling cascadeKatrin Manske, Lisa Dreßler, Simon P Fräßle, et al.
Plos One|May 1, 2012
Novel serial positive enrichment technology enables clinical multiparameter cell sortingChristian Stemberger, Stefan Dreher, Claudia Tschulik, et al.
Scientific Reports|October 21, 2020
Expamers: a new technology to control T cell activationMateusz P Poltorak, Patricia Graef, Claudia Tschulik, et al.
Pageof 1